ATE53495T1 - Moraxella bovis-bakterin. - Google Patents

Moraxella bovis-bakterin.

Info

Publication number
ATE53495T1
ATE53495T1 AT84870169T AT84870169T ATE53495T1 AT E53495 T1 ATE53495 T1 AT E53495T1 AT 84870169 T AT84870169 T AT 84870169T AT 84870169 T AT84870169 T AT 84870169T AT E53495 T1 ATE53495 T1 AT E53495T1
Authority
AT
Austria
Prior art keywords
bacterine
moraxella bovis
bovis
moraxella
protection against
Prior art date
Application number
AT84870169T
Other languages
English (en)
Inventor
Jay Dean Gerber
Original Assignee
Norden Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norden Lab Inc filed Critical Norden Lab Inc
Application granted granted Critical
Publication of ATE53495T1 publication Critical patent/ATE53495T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A61K39/1045—Moraxella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/823—Bacterial vaccine for bovine species, e.g. cattle

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT84870169T 1983-12-12 1984-12-07 Moraxella bovis-bakterin. ATE53495T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/560,780 US4675176A (en) 1983-12-12 1983-12-12 Moraxella bovis protease vaccine
EP84870169A EP0146523B1 (de) 1983-12-12 1984-12-07 Moraxella bovis-Bakterin

Publications (1)

Publication Number Publication Date
ATE53495T1 true ATE53495T1 (de) 1990-06-15

Family

ID=24239341

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84870169T ATE53495T1 (de) 1983-12-12 1984-12-07 Moraxella bovis-bakterin.

Country Status (14)

Country Link
US (1) US4675176A (de)
EP (1) EP0146523B1 (de)
JP (1) JPS60146831A (de)
AT (1) ATE53495T1 (de)
AU (1) AU565941B2 (de)
CA (1) CA1250233A (de)
DE (1) DE3482442D1 (de)
DK (1) DK595084A (de)
ES (1) ES8608320A1 (de)
GR (1) GR81194B (de)
IE (1) IE57878B1 (de)
NZ (1) NZ210490A (de)
PT (1) PT79640B (de)
ZA (1) ZA849616B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4818528A (en) * 1987-02-06 1989-04-04 The University Of Tennessee Research Corporation Vaccine against infectious bovine keratoconjunctivitis
DE3870972D1 (de) * 1987-04-15 1992-06-17 Trw Cam Gears Ltd Fahrzeugservolenkmechanismus.
GB9201013D0 (en) * 1992-01-17 1992-03-11 Animal Health Inst Vaccines
WO1996012502A1 (en) * 1994-10-25 1996-05-02 Kansas State University Research Foundation Method of culturing m. bovis in low available iron media and production of infectious bovine keratoconjunctivitis vaccine therefrom
US7341727B1 (en) * 1996-05-03 2008-03-11 Emergent Product Development Gaithersburg Inc. M. catarrhalis outer membrane protein-106 polypeptide, methods of eliciting an immune response comprising same
AUPQ257199A0 (en) * 1999-08-31 1999-09-23 Commonwealth Scientific And Industrial Research Organisation Vaccine antigens of moraxella
US7220421B2 (en) * 2001-06-19 2007-05-22 The Regents Of The University Of California Moraxella bovis cytotoxin, cytotoxin gene, antibodies and vaccines for prevention and treatment of Moraxella bovis infections
ZA200808673B (en) * 2006-04-11 2009-12-30 Mileutis Ltd Livestock management for improved reproductive efficiency
WO2011044576A2 (en) 2009-10-09 2011-04-14 Children's Medical Center Corporation Selectively disrupted whole-cell vaccine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3197373A (en) * 1962-02-23 1965-07-27 Texas A & M Res Foundation Immunological agent
US3401219A (en) * 1965-08-25 1968-09-10 Merck & Co Inc Moraxella bovis infectious bovine keratoconjunctivitis steam-killed bacterin
US3853990A (en) * 1973-01-22 1974-12-10 E Madigan Infectious kerating bacterin and antiserum and method of preparing same
US4254098A (en) * 1980-01-28 1981-03-03 Clair M. Hibbs Composition for prophylactic treatment of pinkeye
EP0107845A3 (de) * 1982-10-29 1985-07-03 Bactex Incorporated Vakzine für die Immunisierung von Vieh gegen durch Moraxella Bovis verursachte infektiöse Rinder-Keratokonjunctivitis

Also Published As

Publication number Publication date
IE843174L (en) 1985-06-12
AU565941B2 (en) 1987-10-01
JPH0579650B2 (de) 1993-11-04
EP0146523A2 (de) 1985-06-26
IE57878B1 (en) 1993-05-05
PT79640A (en) 1985-01-01
US4675176A (en) 1987-06-23
ES538474A0 (es) 1986-06-16
PT79640B (en) 1986-11-18
ZA849616B (en) 1985-11-27
CA1250233A (en) 1989-02-21
AU3653184A (en) 1985-06-20
DE3482442D1 (de) 1990-07-19
DK595084D0 (da) 1984-12-12
EP0146523B1 (de) 1990-06-13
ES8608320A1 (es) 1986-06-16
DK595084A (da) 1985-06-13
EP0146523A3 (en) 1986-11-26
NZ210490A (en) 1988-09-29
GR81194B (en) 1985-04-05
JPS60146831A (ja) 1985-08-02

Similar Documents

Publication Publication Date Title
FI842423A7 (fi) Pidätyskyvyttömyyssuoja miehiä varten.
DE3484503D1 (de) Fehlerschutzeinrichtung.
ATE12169T1 (de) Arbeits-sitzmoebel.
NL193045B (nl) Oortelefoon.
IT8123935A0 (it) Composizioni per trattamento di tessuti.
ES8203375A1 (es) Procedimiento de preparar triazoloquinoxalin-4-onas substi- tuidas antihipertensoras
NL189272B (nl) Bipolaire transistor.
AU565941B2 (en) Moraxella bovis bacterin
BG39976A3 (en) Method for preparing benzamides
FI850697L (fi) Maetning av ett floede av saed i en skoerdetroeska.
NO147769C (no) Beskyttelsesanordning for leddaksel.
BG40148A3 (bg) Метод за получаване на хетероциклично съединение
IT7923307A0 (it) Collegamento. modulo di protezione per blocchi di
IT8025311A0 (it) Composizioni poliolefiniche autoestinguenti.
ES443276A1 (es) Un procedimiento para la preparacion de nuevas 6-metil-8 be-ta-(sustituido) metilergolinas.
NO147157C (no) Ildledningssystem for antiluftskyts.
IT8123645A0 (it) Composizioni poliolefiniche autoestinguenti.
SU1095611A1 (ru) Хлорид 5-хлорметил-2-этил-8-метил-4Н-м-диоксино-(4,5-с)-пиридиния, обладающий антимикробной активностью
IT8021537A0 (it) Composizioni fungicibe.
BG36931A3 (en) Method for preparing substituted benzamide
IT1121575B (it) Fluoropoliammidi quali coadiuvanti elastomerici di lavorazione per i fluoroelastomeri
FI830639L (fi) Staellbar sammanfogning foer en oevre kant vid ett trappraeck.
IT8122019A0 (it) Manicotto elastico per alte pressioni.
SU1114024A1 (ru) N-(n-фенол)-дихлормалеинимид, проявляющий активность в отношении сульфатвосстанавливающих бактерий
SU1131198A1 (ru) 2-Этоксикарбонил-3-бромметил-4,4-диметилбутенолид-2, проявляющий противостафилококковую активность

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee